(Total Views: 346)
Posted On: 10/09/2018 9:09:45 AM
Post# of 72440
This will make you grateful for IPIX's caution in the Kevetrin clinical trials. Everyone was complaining about how long the Phase 1 safety trial was taking.
Well, AFMD just announced that one patient died and 2 others have had life-threatening reactions to THEIR cancer therapy, in Phase 1 trials.
And here they got $96 million from Genentech for this drug, which now looks doomed.
Does this make you realize how absurd it is that Big Pharma doesn't step up with an offer for a partnership on Kevetrin?
https://endpts.com/one-of-affimeds-new-glass-...r%20trials
Well, AFMD just announced that one patient died and 2 others have had life-threatening reactions to THEIR cancer therapy, in Phase 1 trials.
And here they got $96 million from Genentech for this drug, which now looks doomed.
Does this make you realize how absurd it is that Big Pharma doesn't step up with an offer for a partnership on Kevetrin?
https://endpts.com/one-of-affimeds-new-glass-...r%20trials
(5)
(0)Scroll down for more posts ▼
